Evidence map›Paper›PMID 34165176›Full record

ArticleMolecular medicine reports2021

Circular RNA profiling reveals a potential role of hsa_circ_IPCEF1 in papillary thyroid carcinoma.

Min Guo, Yushuang Sun, Junzhu Ding, Yong Li, Sihan Yang, Yanna Zhao, Xin Jin, Shan-Shan Li

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Min GuoDepartment of Endocrinology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Yushuang SunCollege of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Junzhu DingCollege of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Yong LiDepartment of Endocrinology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Sihan YangDepartment of Endocrinology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Yanna ZhaoDepartment of Endocrinology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Xin JinSchool of Medicine, Nankai University, Tianjin 300071, P.R. China.
Shan-Shan LiSchool of Medicine, Nankai University, Tianjin 300071, P.R. China.
Harbin Medical University · CNFourth Affiliated Hospital of Harbin Medical University · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are a novel type of non‑coding RNAs that are expressed across species and are implicated in cellular biological processes, displaying dysregulated expression in various tumorigeneses. Therefore, circRNA deregulation could be a crucial event in thyroid carcinoma. The present study identified circRNA signatures in several patients with papillary thyroid carcinoma (PTC) to complement the understanding of PTC pathogenesis. Using microarray technology, the circRNA profiles in three pairs of PTC tumors and matching adjacent normal tissues were screened. Differentially expressed circRNAs were further validated by reverse transcription‑quantitative PCR in whole blood from 57 pairs of subjects. Bioinformatics data analyses including miRNA response element prediction, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway, competing endogenous RNA and KEGG Orthology‑Based Annotation System analyses were performed to predict circRNA associations with cancer‑related putative downstream miRNAs and target genes. Receiver operating characteristic curves and the area under the curve (AUC) values were acquired to assess the performance of validated circRNAs in predicting potential associations with PTC. In total, 158 dysregulated circRNAs were identified in PTC tumors relative to adjacent normal tissues. Notably, one downregulated circRNA (hsa_circ_IPCEF1) showed the preferable predictive power (AUC=0.8010, P<0.0001) and interactions with four cancer‑related genes (CASR, CDC25B, NFκB1 and SHOC2). From these analyses, one PTC‑related miRNA (hsa‑miR‑3619‑5p) was identified as a potential target for hsa_circ_IPCEF1 sponging, indicating the hsa_circ_IPCEF1/hsa‑miR‑3619‑5p axis in pathogenesis.

Indexed as

AdultArea Under CurveBiomarkers, TumorCarrier Proteinscdc25 PhosphatasesComputational BiologyFemaleGene Expression Regulation, NeoplasticGene OntologyHumansIntracellular Signaling Peptides and ProteinsMaleMicroRNAsMiddle AgedNF-kappa B p50 SubunitReceptors, Calcium-SensingBiomarkers, TumorCarrier ProteinsCASR protein, humanCDC25B protein, humancdc25 PhosphatasesIntracellular Signaling Peptides and ProteinsIPCEF1 protein, humanMicroRNAsNF-kappa B p50 SubunitNFKB1 protein, humanReceptors, Calcium-SensingRNARNA, CircularSHOC2 protein, humanbiomarkerscircular RNAsmicroarray assaypapillary thyroid carcinoma

Identifiers

PMID34165176
PMCPMC8240180
OpenAlexW3176348787

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.